Graft-Versus-Host Disease–Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology

PURPOSE: As a tumor immunotherapy, allogeneic hematopoietic cell transplantation with subsequent donor lymphocyte injection (DLI) aims to induce the graft-versus-tumor (GVT) effect but often also leads to acute graft-versus-host disease (GVHD). Plasma tests that can predict the likelihood of GVT wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaowen, Yue, Zongliang, Cao, Yimou, Taylor, Lauren, Zhang, Qing, Choi, Sung W., Hanash, Samir, Ito, Sawa, Chen, Jake Y., Wu, Huanmei, Paczesny, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690359/
https://www.ncbi.nlm.nih.gov/pubmed/31406955
http://dx.doi.org/10.1200/PO.18.00365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690359/
https://www.ncbi.nlm.nih.gov/pubmed/31406955
http://dx.doi.org/10.1200/PO.18.00365

Ejemplares similares